Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 1999;30:1223-1229

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hart, R. G.
Right arrow Articles by Asinger, R. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hart, R. G.
Right arrow Articles by Asinger, R. W.

(Stroke. 1999;30:1223-1229.)
© 1999 American Heart Association, Inc.


Original Contributions

Factors Associated With Ischemic Stroke During Aspirin Therapy in Atrial Fibrillation

Analysis of 2012 Participants in the SPAF I–III Clinical Trials

Robert G. Hart, MD; Lesly A. Pearce, MS; Ruth McBride, BS; Robert M. Rothbart, MD; Richard W. Asinger, MD on behalf of the Stroke Prevention in Atrial Fibrillation (SPAF) Investigators

From the University of Texas Health Science Center, San Antonio (R.G.H.); Statistics and Epidemiology Research Corporation, Seattle, Wash (L.A.P., R. McB.); LeBauer Cardiology Associates, Greensboro, NC (R.M.R.); and Hennepin County Medical Center, Minneapolis, Minn (R.W.A.), on behalf of the Stroke Prevention in Atrial Fibrillation (SPAF) Investigators.

Correspondence to Robert G. Hart, MD, Department of Medicine (Neurology), University of Texas Health Science Center, 7703 Floyd Curl Dr, San Antonio, TX 78284. E-mail HartR{at}uthscsa.edu

Background and Purpose—Nonvalvular atrial fibrillation (AF) is a strong, independent risk factor for stroke, but the absolute rate of stroke varies widely among AF patients, importantly influencing the potential benefit of antithrombotic prophylaxis. We explore factors associated with ischemic stroke in AF patients taking aspirin.

Methods—We performed multivariate logistic regression analysis of 2012 participants given aspirin alone or in combination with low, inefficacious doses of warfarin in the Stroke Prevention in Atrial Fibrillation I–III trials followed for a mean of 2.0 years, during which 130 ischemic strokes were observed.

Results—Age (relative risk [RR]=1.8 per decade, P<0.001), female sex (RR=1.6, P=0.01), history of hypertension (RR=2.0, P<0.001), systolic blood pressure >160 mm Hg (RR=2.3, P<0.001), and prior stroke or transient ischemic attack (RR=2.9, P<0.001) were independently associated with increased stroke risk. Regular consumption of >=14 alcohol-containing drinks per week was associated with reduced stroke risk (adjusted RR=0.4, P=0.04). Among SPAF III participants, estrogen hormone replacement therapy was associated with a higher risk of ischemic stroke (adjusted RR=3.2, P=0.007). With the use of these variables, a risk stratification scheme for primary prevention separated participants into those with high (7.1%/y, 22% of the cohort), moderate (2.6%/y, 37% of the cohort), and low (0.9%/y, 41% of the cohort) rates of stroke. Ischemic strokes in low-risk participants were less often disabling (P<0.001).

Conclusions—Patients with AF who have high and low rates of stroke during treatment with aspirin can be identified. However, validation of our risk stratification scheme is necessary before it can be applied with confidence to clinical management. Postmenopausal estrogen replacement therapy and moderate alcohol consumption may additionally modify the risk of stroke in AF, but these findings require confirmation.


Key Words: atrial fibrillation • cerebral embolism • estrogens • risk factors • stroke prevention




This article has been cited by other articles:


Home page
Circ Cardiovasc Qual OutcomesHome page
A. A. Alsheikh-Ali and N.A. M. Estes III
Anticoagulation Control in Atrial Fibrillation: Optimizing Risks and Benefits
Circ Cardiovasc Qual Outcomes, November 1, 2008; 1(2): 72 - 73.
[Full Text] [PDF]


Home page
ChestHome page
S. Manzano-Fernandez, F. J. Pastor, F. Marin, F. Cambronero, C. Caro, D. A. Pascual-Figal, I. P. Garrido, E. Pinar, M. Valdes, and G. Y. H. Lip
Increased Major Bleeding Complications Related to Triple Antithrombotic Therapy Usage in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Artery Stenting
Chest, September 1, 2008; 134(3): 559 - 567.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
D. E. Singer, G. W. Albers, J. E. Dalen, M. C. Fang, A. S. Go, J. L. Halperin, G. Y. H. Lip, and W. J. Manning
Antithrombotic Therapy in Atrial Fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
Chest, June 1, 2008; 133(6_suppl): 546S - 592S.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
Stroke Risk in Atrial Fibrillation Working Group
Comparison of 12 Risk Stratification Schemes to Predict Stroke in Patients With Nonvalvular Atrial Fibrillation
Stroke, June 1, 2008; 39(6): 1901 - 1910.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
M. Stramba-Badiale
Atrial fibrillation subtypes, risk of stroke, and antithrombotic therapy
Eur. Heart J., April 1, 2008; 29(7): 840 - 842.
[Full Text] [PDF]


Home page
EuropaceHome page
M. L. Hansen, N. Gadsboll, G. H. Gislason, S. Z. Abildstrom, T. K. Schramm, F. Folke, J. Friberg, R. Sorensen, S. Rasmussen, H. E. Poulsen, et al.
Atrial fibrillation pharmacotherapy after hospital discharge between 1995 and 2004: a shift towards beta-blockers
Europace, April 1, 2008; 10(4): 395 - 402.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. C. Fang, A. S. Go, Y. Chang, L. Borowsky, N. K. Pomernacki, D. E. Singer, and for the ATRIA Study Group
Comparison of Risk Stratification Schemes to Predict Thromboembolism in People With Nonvalvular Atrial Fibrillation
J. Am. Coll. Cardiol., February 26, 2008; 51(8): 810 - 815.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
N.A. M. Estes III, J. L. Halperin, H. Calkins, M. D. Ezekowitz, P. Gitman, A. S. Go, R. L. McNamara, J. V. Messer, J. L. Ritchie, S. J.W. Romeo, et al.
ACC/AHA/Physician Consortium 2008 Clinical Performance Measures for Adults With Nonvalvular Atrial Fibrillation or Atrial Flutter: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and the Physician Consortium for Performance Improvement (Writing Committee to Develop Clinical Performance Measures for Atrial Fibrillation) Developed in Collaboration With the Heart Rhythm Society
J. Am. Coll. Cardiol., February 26, 2008; 51(8): 865 - 884.
[Full Text] [PDF]


Home page
CirculationHome page
N. A. M. Estes III, J. L. Halperin, H. Calkins, M. D. Ezekowitz, P. Gitman, A. S. Go, R. L. McNamara, J. V. Messer, J. L. Ritchie, S. J.W. Romeo, et al.
ACC/AHA/Physician Consortium 2008 Clinical Performance Measures for Adults With Nonvalvular Atrial Fibrillation or Atrial Flutter: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and the Physician Consortium for Performance Improvement (Writing Committee to Develop Clinical Performance Measures for Atrial Fibrillation)
Circulation, February 26, 2008; 117(8): 1101 - 1120.
[Full Text] [PDF]


Home page
Am J Health Syst PharmHome page
E. A. Nutescu
ASHP Therapeutic Position Statement on Antithrombotic Therapy in Chronic Atrial Fibrillation
Am. J. Health Syst. Pharm., November 1, 2007; 64(21): 2281 - 2291.
[Full Text] [PDF]


Home page
QJMHome page
M. Hughes, G.Y.H. Lip, and on behalf of the Guideline Development Group for t
Risk factors for anticoagulation-related bleeding complications in patients with atrial fibrillation: a systematic review
QJM, October 1, 2007; 100(10): 599 - 607.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
L. Baruch, B. F. Gage, J. Horrow, S. Juul-Moller, A. Labovitz, M. Persson, and M. Zabalgoitia
Can Patients at Elevated Risk of Stroke Treated With Anticoagulants Be Further Risk Stratified?
Stroke, September 1, 2007; 38(9): 2459 - 2463.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
The Stroke Risk in Atrial Fibrillation Working Gro
Independent predictors of stroke in patients with atrial fibrillation: A systematic review
Neurology, August 7, 2007; 69(6): 546 - 554.
[Abstract] [Full Text] [PDF]


Home page
Med Decis MakingHome page
R. Thomson, M. Eccles, R. Wood, and D. J. Chinn
A Cautionary Note on Data Sources for Evidence-Based Clinical Decisions: Warfarin and Stroke Prevention
Med Decis Making, August 1, 2007; 27(4): 438 - 447.
[Abstract] [PDF]


Home page
EuropaceHome page
G. B. Forleo, C. Tondo, L. De Luca, A. D. Russo, M. Casella, V. De Sanctis, F. Clementi, R. L. Fagundes, R. Leo, F. Romeo, et al.
Gender-related differences in catheter ablation of atrial fibrillation
Europace, August 1, 2007; 9(8): 613 - 620.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
N. Dagres, R. Nieuwlaat, P. E. Vardas, D. Andresen, S. Levy, S. Cobbe, D. Th. Kremastinos, G. Breithardt, D. V. Cokkinos, and H. J.G.M. Crijns
Gender-Related Differences in Presentation, Treatment, and Outcome of Patients With Atrial Fibrillation in Europe: A Report From the Euro Heart Survey on Atrial Fibrillation
J. Am. Coll. Cardiol., February 6, 2007; 49(5): 572 - 577.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
M. L. Flaherty, B. Kissela, D. Woo, D. Kleindorfer, K. Alwell, P. Sekar, C. J. Moomaw, M. Haverbusch, and J. P. Broderick
The increasing incidence of anticoagulant-associated intracerebral hemorrhage
Neurology, January 9, 2007; 68(2): 116 - 121.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
Authors/Task Force Members, L. Ryden, E. Standl, M. Bartnik, G. Van den Berghe, J. Betteridge, M.-J. de Boer, F. Cosentino, B. Jonsson, M. Laakso, et al.
Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)
Eur. Heart J., January 1, 2007; 28(1): 88 - 136.
[Full Text] [PDF]


Home page
EuropaceHome page
Writing Committee Members, V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, et al.
ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society
Europace, September 1, 2006; 8(9): 651 - 745.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al.
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation--Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
J. Am. Coll. Cardiol., August 15, 2006; 48(4): 854 - 906.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al.
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
J. Am. Coll. Cardiol., August 15, 2006; 48(4): e149 - e246.
[Full Text] [PDF]


Home page
CirculationHome page
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al.
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
Circulation, August 15, 2006; 114(7): e257 - e354.
[Full Text] [PDF]


Home page
CirculationHome page
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al.
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation--Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
Circulation, August 15, 2006; 114(7): 700 - 752.
[Full Text] [PDF]


Home page
Eur Heart JHome page
Authors/Task Force Members, V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, et al.
ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation executive summary: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society
Eur. Heart J., August 2, 2006; 27(16): 1979 - 2030.
[Full Text] [PDF]


Home page
Eur Heart JHome page
G. Y.H. Lip, T. Watson, and E. Shantsila
Anticoagulation for stroke prevention in atrial fibrillation: is gender important?
Eur. Heart J., August 2, 2006; 27(16): 1893 - 1894.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
P. S. Chan, S. Vijan, F. Morady, and H. Oral
Cost-Effectiveness of Radiofrequency Catheter Ablation for Atrial Fibrillation
J. Am. Coll. Cardiol., June 20, 2006; 47(12): 2513 - 2520.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
L. B. Goldstein, R. Adams, M. J. Alberts, L. J. Appel, L. M. Brass, C. D. Bushnell, A. Culebras, T. J. DeGraba, P. B. Gorelick, J. R. Guyton, et al.
Primary Prevention of Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association Stroke Council: Cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline.
Circulation, June 20, 2006; 113(24): e873 - e923.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
L. B. Goldstein, R. Adams, M. J. Alberts, L. J. Appel, L. M. Brass, C. D. Bushnell, A. Culebras, T. J. DeGraba, P. B. Gorelick, J. R. Guyton, et al.
Primary Prevention of Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association Stroke Council: Cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline.
Stroke, June 1, 2006; 37(6): 1583 - 1633.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
C J Currie, M Jones, J Goodfellow, P McEwan, C L Morgan, C Emmas, and J R Peters
Evaluation of survival and ischaemic and thromboembolic event rates in patients with non-valvar atrial fibrillation in the general population when treated and untreated with warfarin
Heart, February 1, 2006; 92(2): 196 - 200.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
H. Sato, K. Ishikawa, A. Kitabatake, S. Ogawa, Y. Maruyama, Y. Yokota, T. Fukuyama, Y. Doi, S. Mochizuki, T. Izumi, et al.
Low-Dose Aspirin for Prevention of Stroke in Low-Risk Patients With Atrial Fibrillation: Japan Atrial Fibrillation Stroke Trial
Stroke, February 1, 2006; 37(2): 447 - 451.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
E. G. Butchart, C. Gohlke-Barwolf, M. J. Antunes, P. Tornos, R. De Caterina, B. Cormier, B. Prendergast, B. Iung, H. Bjornstad, C. Leport, et al.
Recommendations for the management of patients after heart valve surgery
Eur. Heart J., November 2, 2005; 26(22): 2463 - 2471.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. Rienstra, D. J. Van Veldhuisen, V. E. Hagens, A. V. Ranchor, N. J.G.M. Veeger, H. J.G.M. Crijns, I. C. Van Gelder, and for the RACE Investigators
Gender-Related Differences in Rhythm Control Treatment in Persistent Atrial Fibrillation: Data of the Rate Control Versus Electrical Cardioversion (RACE) Study
J. Am. Coll. Cardiol., October 4, 2005; 46(7): 1298 - 1306.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
H. Arima, R. G. Hart, S. Colman, J. Chalmers, C. Anderson, A. Rodgers, M. Woodward, S. MacMahon, B. Neal, and for the PROGRESS Collaborative Group
Perindopril-Based Blood Pressure-Lowering Reduces Major Vascular Events in Patients With Atrial Fibrillation and Prior Stroke or Transient Ischemic Attack
Stroke, October 1, 2005; 36(10): 2164 - 2169.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
M. A. Smith, L. D. Lisabeth, D. L. Brown, and L. B. Morgenstern
Gender comparisons of diagnostic evaluation for ischemic stroke patients
Neurology, September 27, 2005; 65(6): 855 - 858.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. C. Fang, D. E. Singer, Y. Chang, E. M. Hylek, L. E. Henault, N. G. Jensvold, and A. S. Go
Gender Differences in the Risk of Ischemic Stroke and Peripheral Embolism in Atrial Fibrillation: The AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) Study
Circulation, September 20, 2005; 112(12): 1687 - 1691.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
D. G. Sherman, S. G. Kim, B. S. Boop, S. D. Corley, J. P. DiMarco, R. G. Hart, L. J. Haywood, K. Hoyte, E. S. Kaufman, M. H. Kim, et al.
Occurrence and Characteristics of Stroke Events in the Atrial Fibrillation Follow-up Investigation of Sinus Rhythm Management (AFFIRM) Study
Arch Intern Med, May 23, 2005; 165(10): 1185 - 1191.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart J SupplHome page
M. O'Donnell, G. Agnelli, and J. I. Weitz
Emerging therapies for stroke prevention in atrial fibrillation
Eur. Heart J. Suppl., May 1, 2005; 7(suppl_C): C19 - C27.
[Abstract] [Full Text] [PDF]


Home page
The Annals of PharmacotherapyHome page
W. E Dager, T. G Vondracek, B. A McIntosh, and E. A Nutescu
Ximelagatran: An Oral Direct Thrombin Inhibitor
Ann. Pharmacother., November 1, 2004; 38(11): 1881 - 1897.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
B. F. Gage, C. van Walraven, L. Pearce, R. G. Hart, P. J. Koudstaal, B.S.P. Boode, and P. Petersen
Selecting Patients With Atrial Fibrillation for Anticoagulation: Stroke Risk Stratification in Patients Taking Aspirin
Circulation, October 19, 2004; 110(16): 2287 - 2292.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
D. E. Singer, G. W. Albers, J. E. Dalen, A. S. Go, J. L. Halperin, and W. J. Manning
Antithrombotic Therapy in Atrial Fibrillation: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
Chest, September 1, 2004; 126(3_suppl): 429S - 456S.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
W. E. Dager
Ximelagatran: A New Antithrombotic Option in Atrial Fibrillation
Journal of Cardiovascular Pharmacology and Therapeutics, July 1, 2004; 9(3): 151 - 162.
[Abstract] [PDF]


Home page
HeartHome page
E. Crystal and S. J Connolly
Role of oral anticoagulation in management of atrial fibrillation
Heart, July 1, 2004; 90(7): 813 - 817.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. G. Rockson and G. W. Albers
Comparing the guidelines: anticoagulation therapy to optimize stroke prevention in patients with atrial fibrillation
J. Am. Coll. Cardiol., March 17, 2004; 43(6): 929 - 935.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
Y. Kida
Age and Sex as Independent Risk Factors for Stroke Among Patients With Atrial Fibrillation
JAMA, December 10, 2003; 290(22): 2937 - 2937.
[Full Text] [PDF]


Home page
JAMAHome page
T. J. Wang, J. M. Massaro, and E. J. Benjamin
Age and Sex as Independent Risk Factors for Stroke Among Patients With Atrial Fibrillation--Reply
JAMA, December 10, 2003; 290(22): 2937 - 2937.
[Full Text] [PDF]


Home page
JAMAHome page
D. E. Singer
A 60-Year-Old Woman With Atrial Fibrillation
JAMA, October 22, 2003; 290(16): 2182 - 2189.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. L. Blackshear, W. D. Johnson, J. A. Odell, V. S. Baker, M. Howard, L. Pearce, C. Stone, D. L. Packer, and H. V. Schaff
Thoracoscopic extracardiac obliteration of the left atrial appendage for stroke risk reduction in atrial fibrillation
J. Am. Coll. Cardiol., October 1, 2003; 42(7): 1249 - 1252.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart J SupplHome page
G.Q. Villani, M. Piepoli, P.E. Villani, and A. Capucci
Anticoagulation in atrial fibrillation: what is certain and what is to come
Eur. Heart J. Suppl., September 1, 2003; 5(suppl_H): H45 - H50.
[Abstract] [PDF]


Home page
JAMAHome page
T. J. Wang, J. M. Massaro, D. Levy, R. S. Vasan, P. A. Wolf, R. B. D'Agostino, M. G. Larson, W. B. Kannel, and E. J. Benjamin
A Risk Score for Predicting Stroke or Death in Individuals With New-Onset Atrial Fibrillation in the Community: The Framingham Heart Study
JAMA, August 27, 2003; 290(8): 1049 - 1056.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
V. Roldan, F. Marin, A. D Blann, A. Garcia, P. Marco, F. Sogorb, and G. Y.H Lip
Interleukin-6, endothelial activation and thrombogenesis in chronic atrial fibrillation
Eur. Heart J., July 2, 2003; 24(14): 1373 - 1380.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
R. G. Hart, L. A. Pearce, S. Di Legge, J. D. Spence, A. Tamayo, V. Hachinski, D. M. Green, A. H. Ropper, R. A. Kronmal, B. M. Psaty, et al.
Serum potassium level and dietary potassium intake as risk factors for stroke
Neurology, June 10, 2003; 60(11): 1869 - 1871.
[Full Text] [PDF]


Home page
ANN INTERN MEDHome page
R. G. Hart, J. L. Halperin, L. A. Pearce, D. C. Anderson, R. A. Kronmal, R. McBride, E. Nasco, D. G. Sherman, R. L. Talbert, J. R. Marler, et al.
Lessons from the Stroke Prevention in Atrial Fibrillation Trials
Ann Intern Med, May 20, 2003; 138(10): 831 - 838.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
C. van Walraven, R. G. Hart, G. A. Wells, P. Petersen, P. J. Koudstaal, A. L. Gullov, B. S. P. Hellemons, B. G. Koefed, and A. Laupacis
A Clinical Prediction Rule to Identify Patients With Atrial Fibrillation and a Low Risk for Stroke While Taking Aspirin
Arch Intern Med, April 28, 2003; 163(8): 936 - 943.
[Abstract] [Full Text] [PDF]


Home page
Fam PractHome page
F. H Rutten, E. Hak, W. A. Stalman, T. J. Verheij, and A. W Hoes
Is treatment of atrial fibrillation in primary care based on thromboembolic risk assessment?
Fam. Pract., February 1, 2003; 20(1): 16 - 21.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
S Illien, S Maroto